Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Biotech
Gene editor shelves sole clinical asset, lays off 25% of staff
Despite hitting a clinical “milestone,” Prime Medicine is shelving its sole clinical-stage genetic medicine.
Gabrielle Masson
May 19, 2025 2:28pm
BMS oncology head swings to Syndax—Chutes & Ladders
May 16, 2025 8:30am
FDA pushes back Cytokinetics' heart drug PDUFA to year-end
May 2, 2025 7:48am
M&A remains ‘top priority’ for pharmas in face of tariff threat
Apr 25, 2025 10:41am
A closer look at pharma's top R&D budgets
Apr 4, 2025 9:34am
Top 10 pharma R&D budgets in 2024
Mar 31, 2025 6:00am
